Adma Biologics Inc (ADMA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Adma Biologics Inc   (NASDAQ: ADMA)
 

Adma Biologics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Adma Biologics Inc 's inventory turnover ratio sequentially decreased to 0.83 in the second quarter 2026, unsurprisingly, as the Adma Biologics Inc markets continue to deteriorate, and ADMA's faces growing challenges to bring down its inventories. Adma Biologics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 440 days, from 380 days, in the Mar 31 2026 quarter.

Within Healthcare sector 332 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1497 in the first quarter 2026, to 1852.

ADMA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Adma Biologics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADMA Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 24.99 % 28.99 % 21.28 % 14.47 % 6.48 %
Y / Y Cost of Sales Growth -29.41 % -37.74 % -7.14 % -3.33 % 10.2 %
Inventory Turnover Ratio (TTM) 0.83 0.96 1.12 1.2 1.25
ADMA's Total Ranking # 1852 # 1497 # 1572 # 1572 #
Average inventory processing period 440 381 325 304 291
Seq. Inventory Growth 7.75 % 7.57 % 4.98 % 2.72 % 11.19 %
Seq. Cost of Sales Growth 15.51 % -34.45 % -13.19 % 7.41 % 1.89 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 333
Overall Market # 1852

Inventory Turnover Ratio Statistics
High Average Low
3.59 1.46 0.61
(Dec 31 2014)   (Mar 31 2017)



ADMA Company Profile >> Back to ADMA Efficiency Comparisons >> Compare ADMA Inventory Turnover Ratio to its Competitors

Financial Statements
Adma Biologics Inc 's Inventories $ 239 Millions Visit ADMA's Balance sheet
Adma Biologics Inc 's Cost of Revenues TTM $ 179 Millions Visit ADMA's Income Statement
What are ADMA's Sales? Visit ADMA's Sales by Segment

Other Inventory Turnover Ratios
Adma Biologics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADMA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADMA's Competitors
Inventory Turnover Ratio for ADMA's Suppliers
Inventory Turnover Ratio for ADMA's Customers

You may also want to know
ADMA's Sales Growth Rates ADMA's Pe Price to earnings ratio ADMA's Receivables Turnover Ratio ADMA's Stock Quote
ADMA's Net Income Growth Rates ADMA's Ps Price to Sales ratio ADMA's Sales per Employee ADMA's Asset Turnover Ratio
ADMA's Net Margin ADMA's Pb Price to Book ratio ADMA's Financial Strength Ratios ADMA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Zomedica Corp   2.05 $ 11.772  Millions$ 6  Millions
Standard Biotools Inc   2.02 $ 40.982  Millions$ 20  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Waters Corporation  2.00 $ 2,008.498  Millions$ 1,005  Millions
Clearpoint Neuro Inc   1.96 $ 15.809  Millions$ 8  Millions
Skinhealth Systems Inc   1.95 $ 96.775  Millions$ 50  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Nature s Sunshine Products inc   1.92 $ 131.811  Millions$ 69  Millions
Insulet Corporation  1.91 $ 883.000  Millions$ 462  Millions
Cytek Biosciences Inc   1.90 $ 96.247  Millions$ 51  Millions
Immucell Corporation  1.89 $ 17.409  Millions$ 9  Millions
Pacific Biosciences Of California Inc   1.89 $ 101.369  Millions$ 54  Millions
Safe Pro Group Inc   1.88 $ 1.089  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  1.88 $ 23.839  Millions$ 13  Millions
Sunshine Biopharma Inc   1.87 $ 24.637  Millions$ 13  Millions
Amgen Inc   1.86 $ 11,613.000  Millions$ 6,244  Millions
Ocular Therapeutix Inc   1.84 $ 6.708  Millions$ 4  Millions
Trisalus Life Sciences Inc   1.82 $ 6.508  Millions$ 4  Millions
Halozyme Therapeutics Inc   1.79 $ 292.421  Millions$ 164  Millions
Seastar Medical Holding Corp  1.78 $ 0.126  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenet Healthcare Corp  1.76 $ 605.000  Millions$ 344  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions

Date modified: 2026-09-11T09:50:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.